Serving hundreds of leading biopharmaceutical companies globally:

Generated: December 12, 2018

DrugPatentWatch Database Preview

LUCENTIS Drug Profile

« Back to Dashboard

Summary for Tradename: LUCENTIS

Patents:	149
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for LUCENTIS

Mechanism of Action	Vascular Endothelial Growth Factor Receptor Inhibitors Vascular Endothelial Growth Factor-directed Antibody Interactions

US Patents for LUCENTIS

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	➤ Sign Up	EYED PHARMA (Liege, BE)	➤ Sign Up	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	➤ Sign Up	LegoChem Biosciences, Inc. (Daejeon, KR)	➤ Sign Up	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	➤ Sign Up	Roche Diagnostics Operations, Inc. (Indianapolis, IN)	➤ Sign Up	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	➤ Sign Up	Board of Trustees of Northern Illinois University (DeKalb, IL)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for LUCENTIS

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Canada	2809460	➤ Sign Up
Australia	2011235569	➤ Sign Up
Russian Federation	2635320	➤ Sign Up
World Intellectual Property Organization (WIPO)	2010151703	➤ Sign Up
Country	Document Number	Estimated Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey

Cerilliant

Johnson and Johnson

Mallinckrodt

Cantor Fitzgerald

Express Scripts

Deloitte

US Army

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.